Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny L. Anderson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
AIDS (London, England)|December 21, 2022
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIVMatthew J Gartner, Carolin Tumpach, Ashanti Dantanarayana, et al.
The Journal of Infectious Diseases|April 29, 2017
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral TherapyGabriela Khoury, Rémi Fromentin, Ajantha Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeletonPaul U Cameron, Suha Saleh, Georgina Sallmann, et al.
Plos Pathogens|January 29, 2026
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoirYoury Kim, Jenny L Anderson, Carolin Tumpach, et al.
Cell Reports. Medicine|August 31, 2023
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Youry Kim, James P Cooney, et al.
AIDS (London, England)|December 19, 2018
HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversalMichael A Moso, Jenny L Anderson, Samantha Adikari, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Mayo Clinic Proceedings|December 10, 2025
Ethically Integrating Genomics in Primary Care: An Invitation to Share Implementation Best Practices, Elisa J F Houwink, Karen M Meagher, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
AIDS (London, England)|December 21, 2022
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIVMatthew J Gartner, Carolin Tumpach, Ashanti Dantanarayana, et al.
The Journal of Infectious Diseases|April 29, 2017
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral TherapyGabriela Khoury, Rémi Fromentin, Ajantha Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeletonPaul U Cameron, Suha Saleh, Georgina Sallmann, et al.
Plos Pathogens|January 29, 2026
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoirYoury Kim, Jenny L Anderson, Carolin Tumpach, et al.
Cell Reports. Medicine|August 31, 2023
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Youry Kim, James P Cooney, et al.
AIDS (London, England)|December 19, 2018
HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversalMichael A Moso, Jenny L Anderson, Samantha Adikari, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Mayo Clinic Proceedings|December 10, 2025
Ethically Integrating Genomics in Primary Care: An Invitation to Share Implementation Best Practices, Elisa J F Houwink, Karen M Meagher, et al.
Pageof 3